941 related articles for article (PubMed ID: 15517885)
1. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal BB; Bhardwaj A; Aggarwal RS; Seeram NP; Shishodia S; Takada Y
Anticancer Res; 2004; 24(5A):2783-840. PubMed ID: 15517885
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention in experimental animals.
Namasivayam N
Ann N Y Acad Sci; 2011 Jan; 1215():60-71. PubMed ID: 21261642
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol, a natural chemopreventive agent against degenerative diseases.
Ignatowicz E; Baer-Dubowska W
Pol J Pharmacol; 2001; 53(6):557-69. PubMed ID: 11985329
[TBL] [Abstract][Full Text] [Related]
4. Biological activity of piceatannol: leaving the shadow of resveratrol.
Piotrowska H; Kucinska M; Murias M
Mutat Res; 2012; 750(1):60-82. PubMed ID: 22108298
[TBL] [Abstract][Full Text] [Related]
5. Cancer prevention and treatment with resveratrol: from rodent studies to clinical trials.
Bishayee A
Cancer Prev Res (Phila); 2009 May; 2(5):409-18. PubMed ID: 19401532
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
[TBL] [Abstract][Full Text] [Related]
7. Substituted trans-stilbenes, including analogues of the natural product resveratrol, inhibit the human tumor necrosis factor alpha-induced activation of transcription factor nuclear factor kappaB.
Heynekamp JJ; Weber WM; Hunsaker LA; Gonzales AM; Orlando RA; Deck LM; Jagt DL
J Med Chem; 2006 Nov; 49(24):7182-9. PubMed ID: 17125270
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the retinoblastoma (pRb)-E2F/DP pathway during antiproliferative effects of resveratrol in human epidermoid carcinoma (A431) cells.
Adhami VM; Afaq F; Ahmad N
Biochem Biophys Res Commun; 2001 Nov; 288(3):579-85. PubMed ID: 11676482
[TBL] [Abstract][Full Text] [Related]
9. Anticancer potential of silymarin: from bench to bed side.
Agarwal R; Agarwal C; Ichikawa H; Singh RP; Aggarwal BB
Anticancer Res; 2006; 26(6B):4457-98. PubMed ID: 17201169
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol and cellular mechanisms of cancer prevention.
Shukla Y; Singh R
Ann N Y Acad Sci; 2011 Jan; 1215():1-8. PubMed ID: 21261635
[TBL] [Abstract][Full Text] [Related]
11. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells.
Kim YA; Lee WH; Choi TH; Rhee SH; Park KY; Choi YH
Int J Oncol; 2003 Oct; 23(4):1143-9. PubMed ID: 12963997
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol addiction: to die or not to die.
Shakibaei M; Harikumar KB; Aggarwal BB
Mol Nutr Food Res; 2009 Jan; 53(1):115-28. PubMed ID: 19072742
[TBL] [Abstract][Full Text] [Related]
13. trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.
Cao Z; Fang J; Xia C; Shi X; Jiang BH
Clin Cancer Res; 2004 Aug; 10(15):5253-63. PubMed ID: 15297429
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol and derivatives for the prevention and treatment of cancer.
Fulda S
Drug Discov Today; 2010 Sep; 15(17-18):757-65. PubMed ID: 20692359
[TBL] [Abstract][Full Text] [Related]
15. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
Banerjee S; Bueso-Ramos C; Aggarwal BB
Cancer Res; 2002 Sep; 62(17):4945-54. PubMed ID: 12208745
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential.
Shankar S; Singh G; Srivastava RK
Front Biosci; 2007 Sep; 12():4839-54. PubMed ID: 17569614
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of resveratrol and its sulfated metabolites against human breast cancer cells.
Miksits M; Wlcek K; Svoboda M; Kunert O; Haslinger E; Thalhammer T; Szekeres T; Jäger W
Planta Med; 2009 Sep; 75(11):1227-30. PubMed ID: 19350482
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol suppresses interleukin-1beta-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis.
Shakibaei M; Csaki C; Nebrich S; Mobasheri A
Biochem Pharmacol; 2008 Dec; 76(11):1426-39. PubMed ID: 18606398
[TBL] [Abstract][Full Text] [Related]
19. Modulations of critical cell cycle regulatory events during chemoprevention of ultraviolet B-mediated responses by resveratrol in SKH-1 hairless mouse skin.
Reagan-Shaw S; Afaq F; Aziz MH; Ahmad N
Oncogene; 2004 Jul; 23(30):5151-60. PubMed ID: 15122319
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target.
Lee MH; Choi BY; Kundu JK; Shin YK; Na HK; Surh YJ
Cancer Res; 2009 Sep; 69(18):7449-58. PubMed ID: 19738051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
